As an Executive-in-Residence at Summit Partners, Davide works alongside Summit’s healthcare & life sciences team to identify new investment opportunities and advise growth stage companies focused on the development and commercialization of advanced therapies.
Davide brings more than 25 years of international operational and business management experience in the contract research organization (CRO), life sciences, biotechnology and animal health industries. He joins Summit Partners’ EIR program from Viroclinics-DDL, a Summit-backed virology and immunology contract research organization (CRO), where he had served as CEO since 2020. During his tenure, Davide led Viroclinics-DDL through a period of significant growth and global expansion, culminating in the company’s sale to Cerba Healthcare in 2022. Prior to Viroclinics-DDL, Davide served as CEO of Evolution Research Group and spent nearly two decades with Charles River Laboratories, where he held both commercial and operational roles, including serving as President and Chief Operating Officer of the global organization.
Davide holds a Doctor of Veterinary Medicine from The University of Milan and an Advanced Management Program Certificate of Harvard Business School.